ABOUT US
SCIENCE
CLINICAL PIPELINE
INVESTORS
CONTACT
JUNE 1, 2020
Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron’s Stem Cells
FEBRUARY 11, 2020
Longeveron LLC Announces Completion of Enrollment in Phase 2b Clinical Trial of Longeveron Allogeneic Mesenchymal Stem Cells (LMSCs) in Aging Frailty
DECEMBER 20, 2019
Longeveron LLC Announces Completion of Enrollment in Phase 1 Clinical Trial of Longeveron Allogeneic Mesenchymal Stem Cells (LMSCs) in Alzheimer’s Disease
FEBRUARY 19, 2019
Longeveron LLC will discuss the company's latest clinical research of its stem cell treatments for Aging Frailty at the International Conference on Frailty & Sarcopenia Research, to be held February 20-22 at the Eden Roc Hotel on Miami Beach
JANUARY 18, 2019
Longeveron Co-Chairs, Hosts Symposium At The 2019 World Stem Cell Summit And Phacilitate Leaders World Conferences In Miami
OCTOBER 29, 2018
Longeveron Chief Science Officer Dr. Joshua Hare To Address 2018 TEDCO Stem Cell Symposium
OCTOBER 18, 2018
Longeveron Receives Prestigious NIH Small Business Innovation Research Grant
OCTOBER 05, 2018
Longeveron Chief Science Officer Dr. Joshua Hare To Keynote 2018 HEALinc Future Health Innovation Summit
OCTOBER 03, 2018
Longeveron To Present At The 2018 Cell & Gene Meeting On The Mesa
AUGUST 20, 2018
Longeveron Co-Authors Important ICSFR Task Force Paper on Aging Frailty
JULY 13, 2018
Dr. Joshua Hare To Present Longeveron Regenerative Stem Cell Research At The Sixth Annual Aspen BrainLab
JUNE 21, 2018
Development of Stem Cell Therapies for Aging-related Conditions
MAY 23, 2018
Longeveron Recruiting for Stem Cell Alzheimer’s Trial in South Florida
MAY 22, 2018
Maryland technology development agency awards grant to study stem cells for improving flu vaccine
Longeveron Receives TEDCO Grant to Fund Stem Cell Research
FEBRUARY 27, 2018
First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition as Part of Groundbreaking Clinical Trial
JANUARY 23, 2018
Longeveron Shares Promising State of Regenerative Medicine Research with Experts at the FDA, NIH and Other Leading Organizations at National Conference
JANUARY 22, 2018
Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami
JANUARY 17, 2018
Longeveron developing stem cell treatments for Frailty, Alzheimers and other aging diseases
JANUARY 09, 2018
NIH Awards Longeveron Cutting-Edge Research Grant to Fight ‘Metabolic Syndrome’ of Obesity, High Blood Pressure, Unhealthy Cholesterol and More through Regenerative Medicine
DECEMBER 21, 2017
Longeveron Pioneering Development of Stem Cell Therapies for Aging Frailty
OCTOBER 23, 2017
University Of Miami Miller School of Medicine: Stem Cell Studies Build Momentum toward Therapy for Age-Associated Frailty
OCTOBER 20, 2017
Miami Herald: Stem cell infusions improved health in frail elderly, UM researchers say
OCTOBER 17, 2017
SEPTEMBER 07, 2017
Longeveron Initiates Phase 2b Stem Cell Therapy Trial to Treat Aging Frailty
MAY 22, 2017
Longeveron to Receive Grant from the Maryland Stem Cell Research Fund
MAY 15, 2017
Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Cell Treatment in Frailty Patients
MAY 10, 2017
Longeveron Begins Enrollment of Second Cohort of Phase 1 Trial of Allogeneic Mesenchymal Stem Cells to Treat Alzheimer’s Disease Patients
